VHL Type 2B gene mutation moderates HIF dosage in vitro and in vivo. [electronic resource]
Producer: 20090422Description: 1694-705 p. digitalISSN:- 1476-5594
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.